帕金森病相关便秘的肠道微生态研究进展
Recent Advances in Gut Microecological Research on Parkinson’s Disease-Related Constipation
DOI: 10.12677/acm.2026.161113, PDF,   
作者: 夏杨彬:绍兴文理学院医学院,浙江 绍兴;亓旭晨*:浙江大学医学院附属邵逸夫医院神经外科,浙江 杭州
关键词: 帕金森病便秘肠道微生态肠脑轴α-突触核蛋白粪菌移植Parkinson’s Disease Constipation Gut Microecosystem Gut-Brain Axis α-Synuclein Fecal Microbiota Transplantation
摘要: 帕金森病(Parkinson’s disease, PD)是一种常见于中老年人的神经系统变性疾病,除运动症状外,非运动症状如便秘在疾病早期即可出现,并随病程进展逐渐加重。近年来研究表明,便秘不仅是PD的前驱表现之一,其严重程度还与认知功能衰退密切相关。肠道微生态失调在PD便秘的发生发展中起关键作用,异常聚集的α-突触核蛋白可能经肠神经系统通过迷走神经途径传播至中枢,构成“肠脑轴”病理机制的核心环节。本文围绕PD相关便秘的临床表现、流行病学特征、病理生理机制、影响因素及治疗策略进行综述,重点探讨肠道菌群失调与PD便秘的相互作用及其临床意义,以期为PD的早期干预与综合管理提供新思路。
Abstract: Parkinson’s disease (PD) is a neurodegenerative disorder commonly affecting middle-aged and elderly individuals. In addition to its hallmark motor symptoms, non-motor manifestations such as constipation may emerge in the early stages of the disease and tend to worsen as PD progresses. Recent studies indicate that constipation is not only one of the prodromal features of PD, but its severity is also closely associated with cognitive decline. Increasing evidence suggests that disturbances in the gut microecosystem play a pivotal role in the onset and progression of PD-related constipation. Misfolded α-synuclein aggregates may originate within the enteric nervous system and propagate to the central nervous system via the vagal pathway, forming a core component of the “gut-brain axis” pathological mechanism. This review summarizes the clinical features, epidemiology, pathophysiology, influencing factors, and therapeutic strategies of PD-associated constipation, with a particular emphasis on the interplay between gut microbiota dysbiosis and constipation in PD. We aim to provide new insights that may contribute to early intervention and integrated management of PD.
文章引用:夏杨彬, 亓旭晨. 帕金森病相关便秘的肠道微生态研究进展[J]. 临床医学进展, 2026, 16(1): 848-855. https://doi.org/10.12677/acm.2026.161113

参考文献

[1] Roos, D.S., Klein, M., Deeg, D.J.H., Doty, R.L. and Berendse, H.W. (2022) Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population. Journal of Parkinsons Disease, 12, 967-974. [Google Scholar] [CrossRef] [PubMed]
[2] Santos García, D., García Roca, L., de Deus Fonticoba, T., Cores Bartolomé, C., Naya Ríos, L., Canfield, H., et al. (2022) Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up and Comparison with a Control Group. Journal of Parkinsons Disease, 12, 315-331. [Google Scholar] [CrossRef] [PubMed]
[3] Tansey, M.G., Wallings, R.L., Houser, M.C., Herrick, M.K., Keating, C.E. and Joers, V. (2022) Inflammation and Immune Dysfunction in Parkinson Disease. Nature Reviews Immunology, 22, 657-673. [Google Scholar] [CrossRef] [PubMed]
[4] Kim, S., Kwon, S., Kam, T., Panicker, N., Karuppagounder, S.S., Lee, S., et al. (2019) Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease. Neuron, 103, 627-641.e7. [Google Scholar] [CrossRef] [PubMed]
[5] Tan, A.H., Lim, S.Y. and Lang, A.E. (2022) The Microbiome-Gut-Brain Axis in Parkinson Disease—From Basic Research to the Clinic. Nature Reviews Neurology, 18, 476-495. [Google Scholar] [CrossRef] [PubMed]
[6] Lacy, B.E., Mearin, F., Chang, L., Chey, W.D., Lembo, A.J., Simren, M., et al. (2016) Bowel Disorders. Gastroenterology, 150, 1393-1407.e5. [Google Scholar] [CrossRef] [PubMed]
[7] Yao, L., Liang, W., Chen, J., Wang, Q. and Huang, X. (2022) Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis. European Neurology, 86, 34-44. [Google Scholar] [CrossRef] [PubMed]
[8] Yu, Q., Yu, S., Zuo, L., Lian, T., Hu, Y., Wang, R., et al. (2018) Parkinson Disease with Constipation: Clinical Features and Relevant Factors. Scientific Reports, 8, Article No. 567. [Google Scholar] [CrossRef] [PubMed]
[9] Sun, B., Wang, T., Li, N., Wu, Q. and Qiao, J. (2021) Clinical Features and Relative Factors of Constipation in a Cohort of Chinese Patients with Parkinson’s Disease. World Journal of Gastrointestinal Pharmacology and Therapeutics, 12, 21-31. [Google Scholar] [CrossRef] [PubMed]
[10] Frazzitta, G., Ferrazzoli, D., Folini, A., Palamara, G. and Maestri, R. (2019) Severe Constipation in Parkinson’s Disease and in Parkinsonisms: Prevalence and Affecting Factors. Frontiers in Neurology, 10, Article 621. [Google Scholar] [CrossRef] [PubMed]
[11] Braak, H., Tredici, K.D., Rüb, U., de Vos, R.A.I., Jansen Steur, E.N.H. and Braak, E. (2003) Staging of Brain Pathology Related to Sporadic Parkinson’s Disease. Neurobiology of Aging, 24, 197-211. [Google Scholar] [CrossRef] [PubMed]
[12] Scheperjans, F., Levo, R., Bosch, B., Lääperi, M., Pereira, P.A.B., Smolander, O., et al. (2024) Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial. JAMA Neurology, 81, 925-938. [Google Scholar] [CrossRef] [PubMed]
[13] Sun, M. and Shen, Y. (2018) Dysbiosis of Gut Microbiota and Microbial Metabolites in Parkinson’s Disease. Ageing Research Reviews, 45, 53-61. [Google Scholar] [CrossRef] [PubMed]
[14] Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., et al. (2016) Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell, 167, 1469-1480.e12. [Google Scholar] [CrossRef] [PubMed]
[15] Braak, H. and Del Tredici, K. (2008) Invited Article: Nervous System Pathology in Sporadic Parkinson Disease. Neurology, 70, 1916-1925. [Google Scholar] [CrossRef] [PubMed]
[16] Jellinger, K.A. (2018) Is Braak Staging Valid for All Types of Parkinson’s Disease? Journal of Neural Transmission, 126, 423-431. [Google Scholar] [CrossRef] [PubMed]
[17] Kalaitzakis, M.E., Graeber, M.B., Gentleman, S.M. and Pearce, R.K.B. (2007) The Dorsal Motor Nucleus of the Vagus Is Not an Obligatory Trigger Site of Parkinson’s Disease: A Critical Analysis of α‐Synuclein Staging. Neuropathology and Applied Neurobiology, 34, 284-295. [Google Scholar] [CrossRef] [PubMed]
[18] Visanji, N.P., Marras, C., Kern, D.S., Al Dakheel, A., Gao, A., Liu, L.W.C., et al. (2015) Colonic Mucosal α-Synuclein Lacks Specificity as a Biomarker for Parkinson Disease. Neurology, 84, 609-616. [Google Scholar] [CrossRef] [PubMed]
[19] Horsager, J., Andersen, K.B., Knudsen, K., Skjærbæk, C., Fedorova, T.D., Okkels, N., et al. (2020) Brain-First versus Body-First Parkinson’s Disease: A Multimodal Imaging Case-Control Study. Brain, 143, 3077-3088. [Google Scholar] [CrossRef] [PubMed]
[20] Borghammer, P. and Van Den Berge, N. (2019) Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis. Journal of Parkinsons Disease, 9, S281-S295. [Google Scholar] [CrossRef] [PubMed]
[21] Borghammer, P., Just, M.K., Horsager, J., Skjærbæk, C., Raunio, A., Kok, E.H., et al. (2022) A Postmortem Study Suggests a Revision of the Dual-Hit Hypothesis of Parkinson’s Disease. npj Parkinsons Disease, 8, Article No. 166. [Google Scholar] [CrossRef] [PubMed]
[22] Camacho, M., Macleod, A.D., Maple-Grødem, J., Evans, J.R., Breen, D.P., Cummins, G., et al. (2021) Early Constipation Predicts Faster Dementia Onset in Parkinson’s Disease. npj Parkinsons Disease, 7, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[23] Al-Wardat, M., Grillo, P., Schirinzi, T., Pavese, C., Salimei, C., Pisani, A., et al. (2023) Constipation and Pain in Parkinson’s Disease: A Clinical Analysis. Journal of Neural Transmission, 131, 165-172. [Google Scholar] [CrossRef] [PubMed]
[24] Warnecke, T., Schäfer, K., Claus, I., Del Tredici, K. and Jost, W.H. (2022) Gastrointestinal Involvement in Parkinson’s Disease: Pathophysiology, Diagnosis, and Management. npj Parkinsons Disease, 8, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[25] Yuan, X., Chen, Y. and Liu, Z. (2024) Relationship among Parkinson’s Disease, Constipation, Microbes, and Microbiological Therapy. World Journal of Gastroenterology, 30, 225-237. [Google Scholar] [CrossRef] [PubMed]
[26] Bharucha, A.E. and Lacy, B.E. (2020) Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology, 158, 1232-1249.e3. [Google Scholar] [CrossRef] [PubMed]
[27] Verrotti, A., Prezioso, G., Scattoni, R. and Chiarelli, F. (2014) Autonomic Neuropathy in Diabetes Mellitus. Frontiers in Endocrinology, 5, Article 205. [Google Scholar] [CrossRef] [PubMed]
[28] van der Schoot, A., Drysdale, C., Whelan, K. and Dimidi, E. (2022) The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Clinical Nutrition, 116, 953-969. [Google Scholar] [CrossRef] [PubMed]
[29] Park, J.M., Lee, S.C., Ham, C. and Kim, Y.W. (2023) Effect of Probiotic Supplementation on Gastrointestinal Motility, Inflammation, Motor, Non-Motor Symptoms and Mental Health in Parkinson’s Disease: A Meta-Analysis of Randomized Controlled Trials. Gut Pathogens, 15, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[30] Tan, A.H., Lim, S., Chong, K.K., A Manap, M.A.A., Hor, J.W., Lim, J.L., et al. (2021) Probiotics for Constipation in Parkinson Disease: A Randomized, Double‑Blind, Placebo‑Controlled Study. Neurology, 96, e772-e782. [Google Scholar] [CrossRef] [PubMed]
[31] Elhadi, M., Benghatnsh, A., Msherghi, A., Khaled, A., Khaled, A. and Faraj, H. (2023) Exploring the Benefits of Probiotics for Constipation Management in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Journal of the Neurological Sciences, 455, Article ID: 121754. [Google Scholar] [CrossRef
[32] Ghorbani, Z., Shoaibinobarian, N., Noormohammadi, M., Taylor, K., Kazemi, A., Bonyad, A., et al. (2025) Reinforcing Gut Integrity: A Systematic Review and Meta-Analysis of Clinical Trials Assessing Probiotics, Synbiotics, and Prebiotics on Intestinal Permeability Markers. Pharmacological Research, 216, Article ID: 107780. [Google Scholar] [CrossRef] [PubMed]
[33] Ghalandari, N., Assarzadegan, F., Mahdavi, H., Jamshidi, E. and Esmaily, H. (2023) Evaluating the Effectiveness of Probiotics in Relieving Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Heliyon, 9, e14312. [Google Scholar] [CrossRef] [PubMed]
[34] Ghalandari, N., Assarzadegan, F., Habibi, S.A.H., Esmaily, H. and Malekpour, H. (2023) Efficacy of Probiotics in Improving Motor Function and Alleviating Constipation in Parkinson’s Disease: A Randomized Controlled Trial. Iranian Journal of Pharmaceutical Research, 22, e137840. [Google Scholar] [CrossRef] [PubMed]
[35] Jin, X., Dong, W., Chang, K., Yan, Y. and Liu, X. (2024) Efficacy of Probiotic Supplements on Parkinson’s Disease: A Systematic Review and Meta-analysis. Complementary Therapies in Medicine, 82, Article ID: 103045. [Google Scholar] [CrossRef] [PubMed]
[36] Xie, L., Chen, D., Zhu, X. and Cheng, C. (2023) Efficacy and Safety of Probiotics in Parkinson’s Constipation: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology, 13, Article 1007654. [Google Scholar] [CrossRef] [PubMed]
[37] Nabil, Y., Helal, M.M., Qutob, I.A., Dawoud, A.I.A., Allam, S., Haddad, R., et al. (2025) Efficacy and Safety of Fecal Microbiota Transplantation in the Management of Parkinson’s Disease: A Systematic Review. BMC Neurology, 25, Article No. 291. [Google Scholar] [CrossRef] [PubMed]
[38] Boertien, J.M., Murtomäki, K., Pereira, P.A.B., van der Zee, S., Mertsalmi, T.H., Levo, R., et al. (2022) Fecal Microbiome Alterations in Treatment-Naive De Novo Parkinson’s Disease. npj Parkinsons Disease, 8, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
[39] Cheng, Y., Tan, G., Zhu, Q., Wang, C., Ruan, G., Ying, S., et al. (2023) Efficacy of Fecal Microbiota Transplantation in Patients with Parkinson’s Disease: Clinical Trial Results from a Randomized, Placebo-Controlled Design. Gut Microbes, 15, Article ID: 2284247. [Google Scholar] [CrossRef] [PubMed]